Green Lifescience Co., Ltd. (KOSDAQ:114450)

Market Cap	55.16B +53.0%
Revenue (ttm)	34.66B +60.5%
Net Income	-365.54M
EPS	-19.15
Shares Out	19.53M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	265,251
Average Volume	360,564
Open	2,710.00
Previous Close	2,760.00
Day's Range	2,660.00 - 2,760.00
52-Week Range	1,450.00 - 4,640.00
Beta	0.97
RSI	52.06
Earnings Date	Mar 27, 2026

About Green Lifescience

Green Lifescience Co., Ltd. engages in development, production, and sale of agrochemical raw materials and pharmaceutical intermediates in South Korea and internationally. The company offers raw materials for pharmaceuticals and pesticides; and primary intermediates to the pharmaceutical and agrochemical markets. It also develops EDP-CL, a piperacillin antibiotic intermediate; N,N-disuccinimidyl carbonate used for the synthesis of HIV treatment; Amoxapine, an antidepressant raw drug, and AM19, an antibiotic intermediate, as well as 1,1'-carbony...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2005
• Employees: 70
• Stock Exchange: KOSDAQ
• Ticker Symbol: 114450